# ResMed

a publicly traded medical-device company manufacturing clinical sleep-apnea (CPAP) therapy devices, reporting quarterly earnings and continuing to unveil new digital and personalized sleep-health solutions.


Source: https://en.bioecon.ru/companies/resmed/
Updated: 2026-08-15

- Country: United States
- Ticker: RMD

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | $5.7 billion for fiscal year 2026 (2026-06-30) | https://www.sec.gov/Archives/edgar/data/943819/000119312526337962/d158732dex991.htm |
| Headcount | approximately 11,370 people (2026-06-30) | https://investor.resmed.com/sec-filings/content/0000943819-26-000047/rmd-20260630.htm |
| Production site | Tuas, Singapore; Sydney, Australia; Chatsworth, California; Calabasas, California; Johor Bahru, Malaysia; Atlanta, Georgia; Suzhou, China; Lyon, France (2026-06-30) | https://investor.resmed.com/sec-filings/content/0000943819-26-000047/rmd-20260630.htm |
| Certification | ISO 13485; MDSAP; ISO 14001:2015 for Sydney and Singapore sites (2026-06-30) | https://investor.resmed.com/sec-filings/content/0000943819-26-000047/rmd-20260630.htm |
| Capacity | facility in Tuas, Singapore significantly increased production capacity of masks and serves as primary production location for AirSense 11 device (2022-11-17) | https://newsroom.resmed.com/news-releases/news-details/2022/ResMed-Opens-Manufacturing-Centre-in-Singapore-Expanding-Manufacturing-Footprint-to-Support-Growth-Development-and-Production-of-Digital-Health-Solutions/default.aspx |

Independent sources: sec.gov

## Technologies

- [Sleep and circadian bioeconomy](https://en.bioecon.ru/technology/sleep-circadian-bioeconomy/)